Scientists race to match pancreatic cancer patients with best treatment
NCT ID NCT04469556
Summary
This study compared two standard chemotherapy treatments for people with newly diagnosed, advanced pancreatic cancer that has spread. Researchers tested whether they could use tumor samples and lab tests to predict which treatment would work better for each patient. The goal was to help doctors choose the most effective chemotherapy while developing better tools for future personalized treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Agency Vancouver
Vancouver, British Columbia, V5Z 1L8, Canada
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Northwell Health
New Hyde Park, New York, 11042, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2N9, Canada
Conditions
Explore the condition pages connected to this study.